A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
Recruiting · NCT04928677 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment | Disease Attributes, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Simpson-Golabi-Behmel syndrome, hepatoblastoma, mixed neoplasm, neoplasm | Recruiting | Phase 1 | 2026-09-01 | NCT04928677 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chugai Pharma USA | 1 |
| Memorial Sloan Kettering Cancer Center | 753 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Healthcare of Atlanta (Data Collection Only) | Atlanta | United States | 2 |
| Children's Hospital of Los Angeles (Data Collection Only) | Los Angeles | United States | 4 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Dana Farber Cancer Institute (Data Collection Only) | Boston | United States | 6 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |